{"entity":{"type":"insider","cik":"0001605838","url":"/insider/0001605838","json_url":"/insider/0001605838.json","name":"MDV ENF VII (B), L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":12,"first":"2014-04-16","last":"2016-09-16","span_basis":"filed_date"},"name_variants":[{"name":"MDV ENF VII (B), L.P.","source":"filing","n_filings":12,"first_seen":"2014-04-16","last_seen":"2016-09-16"}],"transactions":[{"id":3086113,"accession":"0001209191-16-141889","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-141889","line_url":"/filing/0001209191-16-141889#line-3","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; MDV IX LP; Ninth MDV Partners, L.L.C.; SCHOENDORF NANCY J; MDV ENF VII (B), L.P.; FEIBER JONATHAN D; MDV VII Leaders' Fund, L.P.; MDV VII LP; Seventh MDV Partners, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8240.0,"shares_display":"8,240","price_per_share":16.8079,"price_display":"16.81","price_state":"stated","total_value":138497.096,"total_display":"138,497.10","shares_owned_after":4031804.0,"shares_owned_after_display":"4,031,804","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2016-09-16","scope":"insider"},{"id":3086108,"accession":"0001209191-16-141889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-141889","line_url":"/filing/0001209191-16-141889#line-2","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; MDV IX LP; Ninth MDV Partners, L.L.C.; SCHOENDORF NANCY J; MDV ENF VII (B), L.P.; FEIBER JONATHAN D; MDV VII Leaders' Fund, L.P.; MDV VII LP; Seventh MDV Partners, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":3300.0,"total_display":"3,300.00","shares_owned_after":4023564.0,"shares_owned_after_display":"4,023,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider"},{"id":3086103,"accession":"0001209191-16-141889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-141889","line_url":"/filing/0001209191-16-141889#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; MDV IX LP; Ninth MDV Partners, L.L.C.; SCHOENDORF NANCY J; MDV ENF VII (B), L.P.; FEIBER JONATHAN D; MDV VII Leaders' Fund, L.P.; MDV VII LP; Seventh MDV Partners, L.L.C.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54537.0,"shares_display":"54,537","price_per_share":16.4253,"price_display":"16.43","price_state":"stated","total_value":895786.5861,"total_display":"895,786.59","shares_owned_after":4023364.0,"shares_owned_after_display":"4,023,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-16","scope":"insider"},{"id":2060882,"accession":"0001209191-16-141471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-141471","line_url":"/filing/0001209191-16-141471#line-2","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (B), L.P.; Seventh MDV Partners, L.L.C.; FEIBER JONATHAN D; MDV IX LP; Ninth MDV Partners, L.L.C.; MDV VII LP; SCHOENDORF NANCY J; MDV VII Leaders' Fund, L.P.; MDV ENF VII (A), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62034.0,"shares_display":"62,034","price_per_share":15.5559,"price_display":"15.56","price_state":"stated","total_value":964994.7006,"total_display":"964,994.70","shares_owned_after":3968827.0,"shares_owned_after_display":"3,968,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-14","scope":"insider"},{"id":2060858,"accession":"0001209191-16-141471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-141471","line_url":"/filing/0001209191-16-141471#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (B), L.P.; Seventh MDV Partners, L.L.C.; FEIBER JONATHAN D; MDV IX LP; Ninth MDV Partners, L.L.C.; MDV VII LP; SCHOENDORF NANCY J; MDV VII Leaders' Fund, L.P.; MDV ENF VII (A), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22342.0,"shares_display":"22,342","price_per_share":15.6537,"price_display":"15.65","price_state":"stated","total_value":349734.9654,"total_display":"349,734.97","shares_owned_after":3906793.0,"shares_owned_after_display":"3,906,793","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-12","filed_date":"2016-09-14","scope":"insider"},{"id":2131578,"accession":"0001209191-16-140846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-140846","line_url":"/filing/0001209191-16-140846#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; MDV VII Leaders' Fund, L.P.; FEIBER JONATHAN D; Seventh MDV Partners, L.L.C.; MDV VII LP; Ninth MDV Partners, L.L.C.; MDV IX LP; SCHOENDORF NANCY J; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60846.0,"shares_display":"60,846","price_per_share":15.68,"price_display":"15.68","price_state":"stated","total_value":954065.28,"total_display":"954,065.28","shares_owned_after":3884451.0,"shares_owned_after_display":"3,884,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-07","filed_date":"2016-09-09","scope":"insider"},{"id":3257618,"accession":"0001209191-16-140473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-140473","line_url":"/filing/0001209191-16-140473#line-2","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV VII Leaders' Fund, L.P.; MDV IX LP; MDV VII LP; FEIBER JONATHAN D; Seventh MDV Partners, L.L.C.; Ninth MDV Partners, L.L.C.; MDV ENF VII (A), L.P.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7200.0,"shares_display":"7,200","price_per_share":14.9972,"price_display":"15.00","price_state":"stated","total_value":107979.84,"total_display":"107,979.84","shares_owned_after":3823605.0,"shares_owned_after_display":"3,823,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-07","scope":"insider"},{"id":3257611,"accession":"0001209191-16-140473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-140473","line_url":"/filing/0001209191-16-140473#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV VII Leaders' Fund, L.P.; MDV IX LP; MDV VII LP; FEIBER JONATHAN D; Seventh MDV Partners, L.L.C.; Ninth MDV Partners, L.L.C.; MDV ENF VII (A), L.P.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43719.0,"shares_display":"43,719","price_per_share":14.7515,"price_display":"14.75","price_state":"stated","total_value":644920.8285,"total_display":"644,920.83","shares_owned_after":3816405.0,"shares_owned_after_display":"3,816,405","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-07","scope":"insider"},{"id":8866779,"accession":"0001209191-15-060844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-060844","line_url":"/filing/0001209191-15-060844#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; MDV VII Leaders' Fund, L.P.; MDV IX LP; SCHOENDORF NANCY J; FEIBER JONATHAN D; Seventh MDV Partners, L.L.C.; MDV VII LP; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8657.0,"shares_display":"8,657","price_per_share":27.5278,"price_display":"27.53","price_state":"stated","total_value":238308.1646,"total_display":"238,308.16","shares_owned_after":287992.0,"shares_owned_after_display":"287,992","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-10","filed_date":"2015-07-14","scope":"insider"},{"id":8495541,"accession":"0001209191-15-060272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-060272","line_url":"/filing/0001209191-15-060272#line-2","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV ENF VII (A), L.P.; MDV IX LP; FEIBER JONATHAN D; MDV VII LP; Seventh MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":27.551,"price_display":"27.55","price_state":"stated","total_value":85408.1,"total_display":"85,408.10","shares_owned_after":296649.0,"shares_owned_after_display":"296,649","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-08","filed_date":"2015-07-09","scope":"insider"},{"id":8495536,"accession":"0001209191-15-060272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-060272","line_url":"/filing/0001209191-15-060272#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV ENF VII (A), L.P.; MDV IX LP; FEIBER JONATHAN D; MDV VII LP; Seventh MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25737.0,"shares_display":"25,737","price_per_share":27.5452,"price_display":"27.55","price_state":"stated","total_value":708930.8124,"total_display":"708,930.81","shares_owned_after":299749.0,"shares_owned_after_display":"299,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-07","filed_date":"2015-07-09","scope":"insider"},{"id":8648294,"accession":"0001209191-15-055487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-055487","line_url":"/filing/0001209191-15-055487#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV IX LP; SCHOENDORF NANCY J; MDV ENF VII (B), L.P.; MDV VII LP; Ninth MDV Partners, L.L.C.; Seventh MDV Partners, L.L.C.; MDV ENF VII (A), L.P.; FEIBER JONATHAN D; MDV VII Leaders' Fund, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15842.0,"shares_display":"15,842","price_per_share":27.5376,"price_display":"27.54","price_state":"stated","total_value":436250.6592,"total_display":"436,250.66","shares_owned_after":325486.0,"shares_owned_after_display":"325,486","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-18","filed_date":"2015-06-22","scope":"insider"},{"id":8186701,"accession":"0001209191-15-048533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-048533","line_url":"/filing/0001209191-15-048533#line-2","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"FEIBER JONATHAN D; MDV ENF VII (A), L.P.; MDV ENF VII (B), L.P.; MDV IX LP; SCHOENDORF NANCY J; Ninth MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Seventh MDV Partners, L.L.C.; MDV VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112073.0,"shares_display":"112,073","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":2019555.46,"total_display":"2,019,555.46","shares_owned_after":341328.0,"shares_owned_after_display":"341,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-29","filed_date":"2015-06-01","scope":"insider"},{"id":8186697,"accession":"0001209191-15-048533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-048533","line_url":"/filing/0001209191-15-048533#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"FEIBER JONATHAN D; MDV ENF VII (A), L.P.; MDV ENF VII (B), L.P.; MDV IX LP; SCHOENDORF NANCY J; Ninth MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Seventh MDV Partners, L.L.C.; MDV VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7483.0,"shares_display":"7,483","price_per_share":18.017,"price_display":"18.02","price_state":"stated","total_value":134821.211,"total_display":"134,821.21","shares_owned_after":453401.0,"shares_owned_after_display":"453,401","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-28","filed_date":"2015-06-01","scope":"insider"},{"id":8866141,"accession":"0001209191-15-045100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-045100","line_url":"/filing/0001209191-15-045100#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV VII Leaders' Fund, L.P.; Seventh MDV Partners, L.L.C.; FEIBER JONATHAN D; MDV ENF VII (B), L.P.; MDV IX LP; MDV ENF VII (A), L.P.; MDV VII LP; Ninth MDV Partners, L.L.C.; SCHOENDORF NANCY J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1643.0,"shares_display":"1,643","price_per_share":18.04,"price_display":"18.04","price_state":"stated","total_value":29639.72,"total_display":"29,639.72","shares_owned_after":460884.0,"shares_owned_after_display":"460,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-18","filed_date":"2015-05-20","scope":"insider"},{"id":8921279,"accession":"0001209191-15-034141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-034141","line_url":"/filing/0001209191-15-034141#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (B), L.P.; MDV IX LP; MDV VII Leaders' Fund, L.P.; MDV VII LP; Ninth MDV Partners, L.L.C.; Seventh MDV Partners, L.L.C.; FEIBER JONATHAN D; MDV ENF VII (A), L.P.; SCHOENDORF NANCY J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37078.0,"shares_display":"37,078","price_per_share":18.557,"price_display":"18.56","price_state":"stated","total_value":688056.446,"total_display":"688,056.45","shares_owned_after":462527.0,"shares_owned_after_display":"462,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-10","filed_date":"2015-04-14","scope":"insider"},{"id":8811820,"accession":"0001209191-15-028056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-028056","line_url":"/filing/0001209191-15-028056#line-2","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; Ninth MDV Partners, L.L.C.; Seventh MDV Partners, L.L.C.; MDV ENF VII (B), L.P.; FEIBER JONATHAN D; SCHOENDORF NANCY J; MDV IX LP; MDV VII Leaders' Fund, L.P.; MDV VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":18.0407,"price_display":"18.04","price_state":"stated","total_value":129893.04,"total_display":"129,893.04","shares_owned_after":499605.0,"shares_owned_after_display":"499,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-19","scope":"insider"},{"id":8811819,"accession":"0001209191-15-028056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-028056","line_url":"/filing/0001209191-15-028056#line-1","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"MDV ENF VII (A), L.P.; Ninth MDV Partners, L.L.C.; Seventh MDV Partners, L.L.C.; MDV ENF VII (B), L.P.; FEIBER JONATHAN D; SCHOENDORF NANCY J; MDV IX LP; MDV VII Leaders' Fund, L.P.; MDV VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4523.0,"shares_display":"4,523","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":81414.0,"total_display":"81,414.00","shares_owned_after":506805.0,"shares_owned_after_display":"506,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-19","scope":"insider"},{"id":6413678,"accession":"0001209191-14-027984","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-027984","line_url":"/filing/0001209191-14-027984#line-6","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV ENF VII (A), L.P.; MDV IX LP; FEIBER JONATHAN D; MDV VII LP; Seventh MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":265150.0,"shares_display":"265,150","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4242400.0,"total_display":"4,242,400.00","shares_owned_after":265150.0,"shares_owned_after_display":"265,150","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-16","scope":"insider"},{"id":6413676,"accession":"0001209191-14-027984","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-027984","line_url":"/filing/0001209191-14-027984#line-5","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV ENF VII (A), L.P.; MDV IX LP; FEIBER JONATHAN D; MDV VII LP; Seventh MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25661.0,"shares_display":"25,661","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":410576.0,"total_display":"410,576.00","shares_owned_after":25661.0,"shares_owned_after_display":"25,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-16","scope":"insider"},{"id":6413673,"accession":"0001209191-14-027984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-027984","line_url":"/filing/0001209191-14-027984#line-4","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV ENF VII (A), L.P.; MDV IX LP; FEIBER JONATHAN D; MDV VII LP; Seventh MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6043.0,"shares_display":"6,043","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":96688.0,"total_display":"96,688.00","shares_owned_after":6043.0,"shares_owned_after_display":"6,043","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-16","scope":"insider"},{"id":6413670,"accession":"0001209191-14-027984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-027984","line_url":"/filing/0001209191-14-027984#line-3","is_derivative":false,"issuer_cik":"0001027621","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001027621","owner_cik":null,"owner_name":"SCHOENDORF NANCY J; MDV ENF VII (A), L.P.; MDV IX LP; FEIBER JONATHAN D; MDV VII LP; Seventh MDV Partners, L.L.C.; MDV VII Leaders' Fund, L.P.; Ninth MDV Partners, L.L.C.; MDV ENF VII (B), L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3146.0,"shares_display":"3,146","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":50336.0,"total_display":"50,336.00","shares_owned_after":3146.0,"shares_owned_after_display":"3,146","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Ten percent owner","n_filings":12,"first_seen":"2014-04-16","last_seen":"2016-09-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001605838","retrieved_at":"2026-08-21T04:43:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}